← back to search

José A. Martínez-Climent

Clinica Universidad de Navarra · ES
Area of research
Pathology and Forensic Medicine · Hematology
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Multiple Myeloma Research and Treatments, and Acute Myeloid Leukemia Research.
h-index
54
citations
8,439
works
261
NIH funding
primary concept
Medicine
email

Recent publications

Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma
Nature Medicine 2023cited by 80position: lastdoi
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women
Annals of Oncology 2023cited by 44position: middledoi
Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up
Annals of Oncology 2022cited by 111position: middledoi
The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma
Blood 2021cited by 59position: middledoi
The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models
Nature Communications 2019cited by 141position: middledoi
PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas
Blood 2019cited by 97position: middledoi
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study
Annals of Oncology 2017cited by 266position: middledoi
Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics
Nature Communications 2016cited by 65position: lastdoi
ODZ1 allows glioblastoma to sustain invasiveness through a Myc-dependent transcriptional upregulation of RhoA
Oncogene 2016cited by 59position: middledoi
Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphoma
Nature Communications 2014cited by 86position: middledoi
Cellular Plasticity Confers Migratory and Invasive Advantages to a Population of Glioblastoma-Initiating Cells that Infiltrate Peritumoral Tissue
Stem Cells 2013cited by 103position: middledoi
Downregulation of FOXP1 is required during germinal center B-cell function
Blood 2013cited by 65position: lastdoi
<i><scp>LITAF</scp></i>, a <scp>BCL</scp>6 target gene, regulates autophagy in mature B‐cell lymphomas
British Journal of Haematology 2013cited by 49position: lastdoi
Germinal centre protein HGAL promotes lymphoid hyperplasia and amyloidosis via BCR-mediated Syk activation
Nature Communications 2013cited by 44position: middledoi
MALT1 Small Molecule Inhibitors Specifically Suppress ABC-DLBCL In Vitro and In Vivo
Cancer Cell 2012cited by 257position: middledoi
Expression of <i>MALT1</i> oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice
Proceedings of the National Academy of Sciences 2012cited by 75position: lastdoi
Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma
Blood 2012cited by 48position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ari Melnick · Cornell University5 papers (2012–2019) · 3 papers (2013–2019)Izidore S. Lossos · University of Miami3 papers (2012–2013) · 3 papers (2013–2019) · 3 papers (2013–2019)Lorena Fontán · Johnson & Johnson (United States)3 papers (2012–2013) · 3 papers (2013–2016) · 3 papers (2013–2019)Yasodha Natkunam · Stanford University3 papers (2012–2013)Xavier Sagaert · VIB-KU Leuven Center for Microbiology3 papers (2013–2019) · 2 papers (2013–2016) · 2 papers (2013–2016)Xiaoyu Jiang · Guizhou Cancer Hospital2 papers (2012–2013) · 2 papers (2013–2016) · 2 papers (2013–2016)Isabel Romero-Camarero · University of Manchester2 papers (2012–2013) · 2 papers (2013–2016)Victoria Sanz‐Moreno · Institute of Cancer Research2 papers (2013–2016) · 2 papers (2013–2019)Isidro Sánchez‐García · Instituto de Investigación Biomédica de Salamanca2 papers (2012–2013)